Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ramipril for the Treatment of COVID-19 (RAMIC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04366050
Recruitment Status : Recruiting
First Posted : April 28, 2020
Last Update Posted : January 20, 2021
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
Rohit Loomba, University of California, San Diego

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 2021
Estimated Study Completion Date : May 2021